Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Petrova denies wrongdoing after positive meldonium test

Published 03/28/2016, 08:25 AM
Updated 03/28/2016, 08:30 AM
© Reuters. Petrova of Bulgaria competes in the women's triple jump final during the 15th IAAF World Championships at the National Stadium in Beijing

By Angel Krasimirov

SOFIA (Reuters) - Bulgarian triple jumper Gabriela Petrova, runner-up at the 2015 European indoor championships in Prague, has denied any wrong-doing after testing positive for the banned substance meldonium.

"I have not violated, in any way, the anti-doping rules and I can move on with my head held high," Petrova told a news conference at the Vasil Levski stadium on Monday.

"I stopped taking this medication in September. I haven't touched it in 2016."

Meldonium, which helps boost blood flow and increases the amount of oxygen taken in by the body, allowing athletes to recover faster while training, was added to the World Anti-Doping Agency's list of banned substances on Jan. 1.

Since then, more than 100 athletes have been found to have used it.

Petrova, who also finished fourth at the world outdoor championships in Beijing last year, failed an out-of-competition drug test on Feb. 6.

The 23-year-old has joined a long list of athletes, including former world tennis number one Maria Sharapova of Russia, who have recorded positive tests for meldonium. [L5N16Z0IW]

"It has nothing to do with the Sharapova case," Petrova said. "She said she took the medication in 2016 to treat a health problem."

The Bulgarian pulled out of the world indoor championships in Portland, Oregon earlier this month.

"She was ready to win the world title but I decided it was better not to participate because we received the information about the positive test several days before the championship," said coach Atanas Atanasov.

Petrova, named Bulgaria's Athlete of the Year in December, is hoping she will avoid a suspension and be able to compete at the Rio Olympics in August.

"I believe the truth will be revealed," she said. "It doesn't sound logical for 150 athletes to have taken the banned substance in an Olympic year."

The use of meldonium was widespread before the ban. One study showed 490 athletes at last year's European Games in Baku had taken it.

© Reuters. Petrova of Bulgaria competes in the women's triple jump final during the 15th IAAF World Championships at the National Stadium in Beijing

Grindeks, the Latvian company that is the main supplier of the drug, says the substance could protect athletes from cell damage but is unlikely to improve their performance.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.